Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • john_nl
    Member
    • Feb 2012
    • 13

    #1

    Combining FPKM values for a gene

    Hello,

    Hopefully this is a simple question that gets a simple answer:

    I just want to map my reads using bowtie to a well defined transcriptome in the form of a cDNA library. This works very nicely, but the problem is that after running it through cufflinks, it gives FPKM values for each transcript isoform that correspond to one gene. Essentially, I want one "score" for each gene- can i just sum FPKM values for each isoform for a given gene?

    ta
  • adamdeluca
    Member
    • Jul 2010
    • 95

    #2
    You can use the -G option to force cufflinks to only estimate expression of the reference transcripts you supply. Supply 1/gene.

    Comment

    • kopi-o
      Senior Member
      • Feb 2008
      • 319

      #3
      You should be able to just sum the FPKMs.

      Comment

      • Simon Anders
        Senior Member
        • Feb 2010
        • 995

        #4
        ARe you sure that cufflinks likes to work on data aligned to the [I]transcriptome[/I[? I suppose you mean by this that you supplied bowtie not with FASTA files for the genome but with files for the tranmscripts. This does not sound like the workflow it is designed for.

        In any case, if you just want to know the expression strength of the genes, would it not be easier to count how many reads fall onto any exon of a given gene, rather than letting cuffdiff deconvolute this into transcripts, and you sum this up again.

        Comment

        • natstreet
          Member
          • Nov 2009
          • 83

          #5
          If you are mapping directly to a transcriptome I would maybe suggest trying RSEM and supplying it with a FASTA file of reference transcripts containing only one isoform per gene. The RSEM paper is here and the website here. RSEM is an R package that uses bowtie as a read mapper by default.

          Comment

          • john_nl
            Member
            • Feb 2012
            • 13

            #6
            Thank you very much for all of your answers. Much appreciated.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              07-31-2026, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 08-03-2026, 10:13 AM
            0 responses
            15 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-31-2026, 02:55 AM
            0 responses
            32 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Working...